“…Malignant esophageal tumors usually produce intermediate signal intensity on T2-weighted images, unless they contain a high amount of extracellular mucin, which characteristically turns them hyperintense on these sequences (45). 18 F-FDG-PET scanning is recommended to improve the accuracy of staging of distant disease in patients who are potential candidates for curative therapy, whereas the value of 18 F-FDG-PET as a predictive marker of response to neoadjuvant therapy remains uncertain (Fig. 8) (49, 50).…”